# DCE MRI in Patients With Pancreatic Cancer

> **NCT02070705** · NA · TERMINATED · sponsor: **OHSU Knight Cancer Institute** · enrollment: 77 (actual)

## Conditions studied

- Familial Pancreatic Cancer
- Pancreatic Adenocarcinoma
- Pancreatic Intraductal Papillary-Mucinous Neoplasm

## Interventions

- **PROCEDURE:** Dynamic Contrast-Enhanced Magnetic Resonance Imaging
- **DRUG:** Ferumoxytol

## Key facts

- **NCT ID:** NCT02070705
- **Lead sponsor:** OHSU Knight Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-01-31
- **Primary completion:** 2024-08-07
- **Final completion:** 2024-08-07
- **Target enrollment:** 77 (ACTUAL)
- **Why stopped:** Loss of funding
- **Last updated:** 2025-07-31

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02070705

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02070705, "DCE MRI in Patients With Pancreatic Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02070705. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*